From United Kingdom:
I am attempting to lower my A1c in preparation for attempting to conceive. I was using Lantus and Humalog and found control relatively easy, I have swapped to Humulin Lente from Lantus on my doctor's advice, but am finding control much harder to achieve. My A1c is okay, but I am getting lots of peaks and dips which I know are potentially dangerous and I fear could get worse with pregnancy. What is the current thinking on using Lantus during pregnancy? I am trying to weigh up the relative risks of using it or continuing with these fluctuations!
There is essentially no useful data on Lantus and pregnancy at this time. There are concerns about a theoretical risk of worsening retinopathy as well as some speculation about potential toxic effects on the fetus (not as a direct effect of Lantus, but rather through stimulation of other factors). Nothing has been demonstrated in humans. Thus, the current recommendation is to not use Lantus during pregnancy. Even so, I have had some patients who used it without apparent ill effect. The only advantage of Lantus is that it is long-acting with no real peak in activity. You should be able to achieve quite good control using NPH (probably two injections daily) along with Humalog (lispro) prior to each meal. By the way, I would strongly recommend that you add a folate supplement to your diet (4-5 mg/daily). This is to reduce the risk of spina bifida in the developing fetus.
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:10:02
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.